Influence of taking aristolochic acid-containing Chinese drugs on occurence of urinary transitional cell cancer in uremic patients undergoing dialysis

National Medical Journal of China

Volumn 85, Issue 35, 2005, Pages 2487-2491

  Li, Wei Hua ^a   Yang, Li ^a   Su, Tao ^a   Song, Yi ^a   Li, Xiao Mei ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Aristolochic acid; Carcinoma, transitional cell; Peritoneal dialysis; Renal dialysis; Uremia

Indexed keywords

ARISTOLOCHIC ACID; CHINESE DRUG; NUCLEAR MATRIX PROTEIN 22;

ADULT; AGED; ANAMNESIS; ANURIA; ARTICLE; BLADDER TUMOR; CONTROLLED STUDY; DIALYSIS; DRUG OVERDOSE; FEMALE; HEALTH SURVEY; HEMATURIA; HUMAN; HUMAN CELL; IMAGE ANALYSIS; KIDNEY DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PATIENT MONITORING; PREVALENCE; PROTEIN ANALYSIS; QUESTIONNAIRE; RECURRENCE RISK; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; TRANSITIONAL CELL CARCINOMA; UREMIA; URETER TUMOR; URINALYSIS; URINARY TRACT TUMOR;

ADULT; AGED; AGED, 80 AND OVER; ARISTOLOCHIC ACIDS; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 25844445880     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Vanherweghem JL, Depierreuw M, Tielemans C, et al. Rapidly progressive interatitial renal fibrosis in young woman: association with slimming regimen including Chinese herbs. Lanct, 1993, 341:387-391.
2. Li XM, Yang L, Yu Y, et al. An analysis of the clinical and pathological characteristics of Mu-Tong (a Chinese herb) induced tubulointerstitial nephropathy. Chin J Intern Med, 2001, 40:681-687.
3. Hu WX, Liu ZH, Cheng Z, et al. Clinical and pathological features in patients with renal injury associated with aristolochia manshuriensis Kom. J Nephrol Dialy Transplant, 2003,12:504-511.
4. Cosyns JP, Jadoul M, Squifflet JP, et al. Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis, 1999, 33: 1011-1017.
5. Nortier JL, Martinez MCM, Schmeiser HH, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristoloqrpdjchia fangchi). N Engl J Med, 2000, 342: 1686-1692.
6. Chen W, Chen YP, Li A. Uroepithelial carcinoma in patients with chronic aristolochic acid nephropathy. Chin J Nephrol,2004, 20:15-17.
7. Wang ZM. Analysis of Chinese herbs with astolochic acid. Chin J Chin Materia Medica,2002, 27: 801-888.
8. Su T, Yang L, Li XM. Clinical and pathological mechanisms of aristolochic acid nephropathy. Adverse Drug React J,2004, 4:217-225.
9. Cosyns JP. Aristolochic acid and "Chinese herbs nephropathy": A review of the evidence to date. Drug, 2003, 26: 33-48.
10. Yu SM, Zang MF, Xia M, et al. Introduction of urothelial carcinoma. in: Wu JP ed. Wujieping urology. 2nd. Shandong: Shandong Scientific Publishing Hause, 2004.919-942.
11. Chen KS, Lai MK, Huang CC, et al. Agrologic cancers in uremic patients. Am J Kidney Dis, 1995, 25: 694.
12. Liu NB, Bian WJ, Fang ZL, et al. Urothelial malignancy in patients with hemodialysis. Chinese Hemodialysis, 2003, 2: 482-484.
13. Cosyns JP, Jadoul M, Squifflet JP, et al. Urothelial malignancy in nephropathy due to Chinese herbs. Lancet, 1994,344:188.
14. Mengs U, Lang W, Poch JA. The carcinogenic action of aristolochic acid in rats. Arch Toxicol, 1982,51:107-119.
15. Gao YL, Zou WZ, Dong HR, et al. Experimental study of Guau-Mu-Tong-induced cancer in rats. Chin J Nephrol, 2003, 19: 250-253.
16. Liu ZH, Li Y, Qiu Q, et al. Long term effects and malignancy after acute renal injury induced by aristolochic acid I. J Nephrol Dialy Transplant, 2003, 12:318-323.
17. Su T, Qu L, Zhang CL, et al. Studies on pharmacodynamic characteristics of aristolochic acid I in rats. Chin J Chin Materia Medica, 2004, 29:676-681.
18. Bieler CA, Stiborova M, Wiessler M, et al. 32P-post-labelling analysis of DNA adducts formed by arisolochic acid in tissues form patients with Chinese herbs nephropathy. Carinogenesis, 1997, 18: 1063-1067.
19. SchmeiserHH, JanssenJWG, Lons J, et al. Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues. Cancer Res, 1990, 50: 5464-5469.
20. Nortier JL, Heinz H, et al. Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure. Nephrol Dial Transplant, 2003, 18: 426-428.
21. You R, Song WD, Ding Y, et al. Assessment of urinary NMP-22and cytology in diagnosis of the bladder cancer. Chin J Urol,2003,24: 751-752.